HKD 1.32
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 390.81 Million CNY | 14.74% |
2022 | 405 Million CNY | 6.5% |
2021 | 380.29 Million CNY | 222.13% |
2020 | 118.05 Million CNY | 18.44% |
2019 | 99.67 Million CNY | 180.24% |
2018 | 35.56 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 74.74 Million CNY | 0.0% |
2024 Q1 | 74.74 Million CNY | -60.73% |
2023 Q3 | 114.22 Million CNY | -4.71% |
2023 FY | 464.69 Million CNY | 14.74% |
2023 Q4 | 190.33 Million CNY | 66.62% |
2023 Q2 | 119.87 Million CNY | 0.0% |
2023 Q1 | 119.87 Million CNY | -12.78% |
2022 Q3 | 137.43 Million CNY | 72.1% |
2022 Q2 | 79.85 Million CNY | 0.0% |
2022 Q1 | 79.85 Million CNY | 9.32% |
2022 FY | 405 Million CNY | 6.5% |
2022 Q4 | 137.43 Million CNY | 0.0% |
2021 Q1 | 993.38 Million CNY | 555.23% |
2021 Q2 | 993.38 Million CNY | 0.0% |
2021 Q4 | 73.05 Million CNY | 0.0% |
2021 Q3 | 73.05 Million CNY | -92.65% |
2021 FY | 380.29 Million CNY | 222.13% |
2020 Q4 | 151.6 Million CNY | 0.0% |
2020 Q1 | 32.9 Million CNY | 0.2% |
2020 Q2 | 32.9 Million CNY | 0.0% |
2020 FY | 118.05 Million CNY | 18.44% |
2019 FY | 99.67 Million CNY | 180.24% |
2019 Q4 | 32.83 Million CNY | 0.0% |
2018 FY | 35.56 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | -20.232% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 47.134% |